Collaboration to focus on the development of a formulation of Senju’s SJP-0035 for use with Eyenovia’s Optejet® dispensing technology, following consultation with FDA Chronic dry eye ...

This structure affords Senju an opportunity to collaborate with Théa Open Innovation (Laboratoires Théa or Théa), Kiora's exclusive global development and commercialization partner for KIO-301 ...

As the first female gang leader in Tokyo Revengers, Senju Kawaragi commands the Brahman gang and stands among the Three Deities of Kantou— symbols of peak delinquent power.

Senju Pharmaceutical Co., Ltd., a researched-based Japanese pharmaceutical company focusing the field of ophthalmology, and Novaliq GmbH, a biopharmac ...

Hiroshi Senju’s new series of black-and-white cliff paintings, on view now in his exhibition “At World’s End” at Sundaram Tagore’s Chelsea location, are intricately detailed in ...

Senju in northeastern Tokyo developed 400 years ago as a post town providing lodging for travelers. We explore this historic area and meet the people and places at the heart of the community.

The Hiroshi Senju Museum Karuizawa, which opened on Oct. 10 in the mountain resort of Karuizawa, Nagano Prefecture, is named for the artist whose work it celebrates, but it is no less a monument ...

This structure affords Senju an opportunity to collaborate with Théa Open Innovation (Laboratoires Théa or Théa), Kiora's exclusive global development and commercialization partner for KIO-301 ...

Addressing the issue of obviousness, the U.S. Court of Appeals for the Federal Circuit adopted a deferential review stance toward the district court’s ...

Tokyo Revengers Chapter 240 features a much-anticipated return and documents the progress of Takemichi’s new gang. A shocking secret is revealed about Mikey’s past and his current state of mind.

“We are entering a world where attention is going to be scarcer as the cost of creating content approaches zero,” said Hikari Senju, who typifies the successful tech entrepreneur with an ...

Japan's Senju Pharmaceutical has licensed U.S.-based Eyenovia's portfolio of microdosed ophthalmic treatments to develop and market throughout Asia. Financial arrangements were not disclosed, but ...